Related references
Note: Only part of the references are listed.Identification of proteins that mediate the pro-viral functions of the interferon stimulated gene 15 in hepatitis C virus replication
Catherine I. Real et al.
ANTIVIRAL RESEARCH (2013)
Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV Infection
Elizabeth B. Wilson et al.
SCIENCE (2013)
Persistent LCMV Infection Is Controlled by Blockade of Type I Interferon Signaling
John R. Teijaro et al.
SCIENCE (2013)
HIV-1 infection of human macrophages directly induces viperin which inhibits viral production
Najla Nasr et al.
BLOOD (2012)
Cell-Type Specific Interferon Stimulated Gene Staining in Liver Underlies Response to Interferon Therapy in Chronic HBV Infected Patients
Yanling Zhu et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
Hepatic Cell-Type Specific Gene Expression Better Predicts HCV Treatment Outcome Than IL28B Genotype
Ian McGilvray et al.
GASTROENTEROLOGY (2012)
HCV Infection Induces a Unique Hepatic Innate Immune Response Associated With Robust Production of Type III Interferons
Emmanuel Thomas et al.
GASTROENTEROLOGY (2012)
Will IL28B polymorphism remain relevant in the era of direct-acting antiviral agents for hepatitis C virus?
Alexander J. Thompson et al.
HEPATOLOGY (2012)
PD-1 blockade during chronic SIV infection reduces hyperimmune activation and microbial translocation in rhesus macaques
Ravi Dyavar Shetty et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Preactivation of the interferon signalling in liver is correlated with nonresponse to interferon alpha therapy in patients chronically infected with hepatitis B virus
C. Xiao et al.
JOURNAL OF VIRAL HEPATITIS (2012)
New developments in the induction and antiviral effectors of type I interferon
Su-Yang Liu et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
Interferon-Induced Gene Expression Is a Stronger Predictor of Treatment Response Than IL28B Genotype in Patients With Hepatitis C
Michael T. Dill et al.
GASTROENTEROLOGY (2011)
Treatment Failure and Resistance with Direct-Acting Antiviral Drugs Against Hepatitis C Virus
Jean-Michel Pawlotsky
HEPATOLOGY (2011)
The Interferon-Inducible Gene viperin Restricts West Nile Virus Pathogenesis
Kristy J. Szretter et al.
JOURNAL OF VIROLOGY (2011)
USP18-Based Negative Feedback Control Is Induced by Type I and Type III Interferons and Specifically Inactivates Interferon α Response
Veronique Francois-Newton et al.
PLOS ONE (2011)
ISG15 over-expression inhibits replication of the Japanese encephalitis virus in human medulloblastoma cells
Nai-Wan Hsiao et al.
ANTIVIRAL RESEARCH (2010)
Identification of USP18 as an Important Regulator of the Susceptibility to IFN-α and Drug-Induced Apoptosis
Harish Potu et al.
CANCER RESEARCH (2010)
Cell-Type Specific Gene Expression Signature in Liver Underlies Response to Interferon Therapy in Chronic Hepatitis C Infection
Limin Chen et al.
GASTROENTEROLOGY (2010)
Resistance to Direct Antiviral Agents in Patients With Hepatitis C Virus Infection
Christoph Sarrazin et al.
GASTROENTEROLOGY (2010)
The interferon stimulated gene 15 functions as a proviral factor for the hepatitis C virus and as a regulator of the IFN response
Ruth Broering et al.
GUT (2010)
ISG15, a ubiquitin-like interferon-stimulated gene, promotes hepatitis C virus production in vitro: implications for chronic infection and response to treatment
Limin Chen et al.
JOURNAL OF GENERAL VIROLOGY (2010)
Inhibition of Hepatitis C Virus Replication by IFN-Mediated ISGylation of HCV-NS5A
Min-Jung Kim et al.
JOURNAL OF IMMUNOLOGY (2010)
Innate Immune Activation in Primary HIV-1 Infection
J. Judy Chang et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Interferon-Lambda: A New Addition to an Old Family
Raymond P. Donnelly et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2010)
The IFITM Proteins Mediate Cellular Resistance to Influenza A H1N1 Virus, West Nile Virus, and Dengue Virus
Abraham L. Brass et al.
CELL (2009)
ISG15 modification of filamin B negatively regulates the type I interferon-induced JNK signalling pathway
Young Joo Jeon et al.
EMBO REPORTS (2009)
National Institutes of Health Consensus Development Conference Statement: Management of Hepatitis B
Michael F. Sorrell et al.
HEPATOLOGY (2009)
Antiviral Activity of Innate Immune Protein ISG15
Ronald N. Harty et al.
JOURNAL OF INNATE IMMUNITY (2009)
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Dongliang Ge et al.
NATURE (2009)
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
David L. Thomas et al.
NATURE (2009)
Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
Yasuhito Tanaka et al.
NATURE GENETICS (2009)
ISG56 is a negative-feedback regulator of virus-triggered signaling and cellular antiviral response
Ying Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Gene expression profiling reveals similarities between the in vitro and in vivo responses of immune effector cells to IFN-α
Jason M. Zimmerer et al.
CLINICAL CANCER RESEARCH (2008)
Hepatic gene expression and prediction of therapy response in chronic hepatitis C patients
Nazia Selzner et al.
JOURNAL OF HEPATOLOGY (2008)
The Level of Hepatitis B Virus Replication Is Not Affected by Protein ISG15 Modification but Is Reduced by Inhibition of UBP43 (USP18) Expression
Jung-Hwan Kim et al.
JOURNAL OF IMMUNOLOGY (2008)
Immune activation and inflammation in HIV-I infection: causes and consequences
V. Appay et al.
JOURNAL OF PATHOLOGY (2008)
The Cellular Antiviral Protein Viperin Is Attenuated by Proteasome-Mediated Protein Degradation in Japanese Encephalitis Virus-Infected Cells
Yi-Lin Chan et al.
JOURNAL OF VIROLOGY (2008)
Filamin B Serves as a Molecular Scaffold for Type I Interferon-induced c-Jun NH2-terminal Kinase Signaling Pathway
Young Joo Jeon et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection
David G. Brooks et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
ISG15 inhibit Ebola VP40VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity
Atsushi Okumura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Vaccinia virus E3 protein prevents the antiviral action of ISG15
Susana Guerra et al.
PLOS PATHOGENS (2008)
Negative feedback regulation of RIG-1-mediated antiviral signaling by interferon-induced ISG15 conjugation
Min-Jung Kim et al.
JOURNAL OF VIROLOGY (2008)
Interferon-inducible antiviral effectors
Anthony J. Sadler et al.
NATURE REVIEWS IMMUNOLOGY (2008)
The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts
Xiuyan Wang et al.
CELL HOST & MICROBE (2007)
Multiplex analysis of serum cytokines in melanoma patients treated with interferon-α2b
Zoya R. Yurkovetsky et al.
CLINICAL CANCER RESEARCH (2007)
IL-10, T cell exhaustion and viral persistence
Shawn D. Blackburn et al.
TRENDS IN MICROBIOLOGY (2007)
IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses
Deborah J. Lenschow et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Interleukin-10 determines viral clearance or persistence in vivo
David G. Brooks et al.
NATURE MEDICINE (2006)
Silencing of USP18 potentiates the antiviral activity of interferon against hepatitis C virus infection
Glenn Randall et al.
GASTROENTEROLOGY (2006)
Resolution of a chronic viral infection after interleukin-10 receptor blockade
Mette Ejrnaes et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets
Joyce Jing Yi Wong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
H Kato et al.
NATURE (2006)
Toll-like receptor function and signaling
Tsuneyasu Kaisho et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
The interferon-inducible ubiquitin-protein isopeptide ligase (E3) EFP also functions as an ISG15 E3 ligase
WG Zou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Restoring function in exhausted CD8 T cells during chronic viral infection
DL Barber et al.
NATURE (2006)
Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15
A Okumura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The immune response during hepatitis B virus infection
Antonio Bertoletti et al.
JOURNAL OF GENERAL VIROLOGY (2006)
Ube1L and protein ISGylation are not essential for alpha/beta interferon signaling
KI Kim et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Identification of interferon-stimulated gene 15 as an antiviral molecule during Sindbis virus infection in vivo
DJ Lenschow et al.
JOURNAL OF VIROLOGY (2005)
Mechanisms of type-I- and type-II-interferon-mediated signalling
LC Platanias
NATURE REVIEWS IMMUNOLOGY (2005)
Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection
LM Chen et al.
GASTROENTEROLOGY (2005)
Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I
R Stumper et al.
JOURNAL OF VIROLOGY (2005)
Immunology of hepatitis B virus and hepatitis C virus infection
B Rehermann et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Global epidemiology of hepatitis C virus infection
CW Shepard et al.
LANCET INFECTIOUS DISEASES (2005)
Viral infection and Toll-like receptor agonists induce a differential expression of type I and λ interferons in human plasmacytoid and monocyte-derived dendritic cells
EM Coccia et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection
KJ Ritchie et al.
NATURE MEDICINE (2004)
Interferon-inducible ubiquitin E2, Ubc8, is a conjugating enzyme for protein ISGylation
KI Kim et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-α/β-induced ubiquitin-like protein
C Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Protein ISGylation modulates the JAK-STAT signaling pathway
OA Malakhova et al.
GENES & DEVELOPMENT (2003)
Dysregulation of protein modification by ISG15 results in brain cell injury
KJ Ritchie et al.
GENES & DEVELOPMENT (2002)
The relationship between simian immunodeficiency virus RNA levels and the mRNA levels of alpha/beta interferons (IFN-α/β) and IFN-α/β-inducible Mx in lymphoid tissues of rhesus macaques during acute and chronic infection
K Abel et al.
JOURNAL OF VIROLOGY (2002)
UBP43 (USP18) specifically removes ISG15 from conjugated proteins
MP Malakhov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus
KC Chin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein
WM Yuan et al.
EMBO JOURNAL (2001)
Ubiquitin-like proteins: new wines in new bottles
ETH Yeh et al.
GENE (2000)